N-Phenylacetyl-L-Prolylglycine ethyl ester; GVS-111; SGS 111
157115-85-0
318.4
C17H22N2O4
DMF, DMSO, Ethanol, PBS (pH 7.2)
-20°C
A novel proline-containing dipeptide with nootropic effects and cognition-enhancing activity. Noopept has been used in a wide array of animal studies and has been used in a study to test its efficacy compared to piracetam in the treatment of people with traumatic brain injuries to increase mental performance, including learning, memory and cognitive enhancement.
Applications:
• Rescues a-synuclein amyloid toxicity in cellular models
• Stimulates the expression of NGF and BDNF in rat hippocampus
• Improves viability of hippocampal HT-22 neurons in a glutamate toxicity model
• Normalizes blood glucose level and tolerance to glucose load in a streptozotocin diabetic rat model of developing diabetes
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
